Cell: Researchers have identified a 14-protein biomarker signature capable of predicting lung cancer an average of 5.6 years before clinical diagnosis, including among individuals with no history of smoking. Equally compelling is the discovery of an anti-inflammatory therapy that may help prevent disease progression. Perhaps most striking, these proteins do not appear to originate from the cancer cells themselves, challenging longstanding assumptions about tumor biology and opening new avenues for early detection and prevention.
Link to original paper: https://www.cell.com/cell/fulltext/S0092-8674(26)00522-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867426005222%3Fshowall%3Dtrue
Sorena Nadaf-Rahrov, MS, MMI, PhDc
President & CEO - Cancer Center Informatics Society (Ci4CC)
-Chief Health AI Strategy Officer
-Executive Director Precision Oncology Initiatives
Administrative Support
Mary Jo Kronberger